AgingResearch.News
Diagnostics

Advancements in CRISPR/Cas Technologies for Sensitive Cancer Detection: Mechanisms, Platforms, and Clinical Translation Roadmap

By Rokeya Akter, Sook-Won Ryu, Jong-Han Lee
Figure 1. The evolution history of CRISPR/Cas technology based on diagnostic milestones.
Open the figure at full size
Figure 1. The evolution history of CRISPR/Cas technology based on diagnostic milestones.The evolution history of CRISPR/Cas technology based on diagnostic milestones.Akter et al.
ReviewBiomarkers
Paper

The paper

Rokeya Akter, Sook-Won Ryu, Jong-Han Lee

Yonsei University

Diagnostics, 11 Aug 2026

doi.org/10.3390/diagnostics16162531PubMed 42650936

Related